Why the study?
Does cardiogoniometry (CGM) improve the diagnosis of coronary artery disease in patients with suspected stable ischemic heart disease?
Does cardiogoniometry (CGM) improve the diagnosis of coronary artery disease in patients with suspected stable ischemic heart disease?
Cardiogoniometry may be a useful non-invasive modality for risk stratifying CAD in patients with suspected SIHD, particularly those with contraindications for stress tests.
= 75.9%). Regarding Egger's regression test (P = 0.32), there was no published bias in the studies.It seems that CGM, as an easy-to-use and non-invasive modality, should be considered as a part of risk stratifying strategies for CAD in patients with SIHD, mainly in patients with contraindications for stress tests. However, further studies with a high quality of methodology are still needed to assess the diagnostic value of CGM for CAD in patients with suspected SIHD.
No takes yet. Share an insight, caveat, or question.
Shamloo et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: